Project Details
Description
Objectives
The specific experimental objective of this project is to measure adiponectin levels in available plasma samples from dSSC patients treated with dasatinib and evaluate correlations with QLF, serum biomarkers, skin score and measures of lung function. More broadly, these data on adiponectin will potentially contribute to the further validation of adiponectin and other non-invasive biomarkers for the monitoring and treatment of pulmonary fibrosis.
Status | Finished |
---|---|
Effective start/end date | 12/18/12 → 12/18/15 |
Funding
- Bristol-Myers Squibb Company (Agmt 12/18/12)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.